Thyroid cancer cells were incubated with ice-cold cell lysis buffer, scraped and centrifuged, and the supernatant was stored at −80 °C. Twenty-five micrograms of total protein lysate were suspended in reduced SDS sample buffer and the lysates were subjected to SDS–PAGE (4–12%). The separated proteins were transferred to a
nitrocellulose membrane (Invitrogen, Life Technologies Corp., Carlsbad, CA, USA) by electrophoretic blotting.
Membranes were incubated overnight with primary antibody against
β-actin (Sigma–Aldrich),
p-AKT1/2/3 (Ser473), total AKT,
p-ERK1/2, total ERK,
cleaved caspase 3,
phospho-p70S6K (Thr389), phospho-pS6 (Ser235/236), phospho-AMPK (Thr172), total AMPK,
cytochrome c oxidase subunit 4 (COX4) (Cell Signaling Technology, Danvers, MA, USA),
γH2AX,
cyclin D1 and
β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Detection of proteins was performed using the
Li-Cor Odyssey imaging system (LI-COR Biosciences, Lincoln, NE, USA).
Image Studio Lite version 3.1 (Licor) was used for band densitometry measurement and quantification of protein levels.
Bikas A., Jensen K., Patel A., Costello J., Reynolds S.M., Mendonca-Torres M.C., Thakur S., Klubo-Gwiezdzinska J., Ylli D., Wartofsky L., Burman K, & Vasko V. (2020). Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer. Cancers, 12(9), 2548.